Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis (UC) Participants Who Are Naive to Tumor Necrosis Factor (TNF) Inhibitors

ClinicalTrials.gov ID: NCT02165215

Public ClinicalTrials.gov record NCT02165215. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 12:58 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy (Maintenance of Remission) and Safety of Etrolizumab Compared With Placebo in Patients With Moderate to Severe Active Ulcerative Colitis Who Are Naive to TNF Inhibitors

Study identification

NCT ID
NCT02165215
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
359 participants

Conditions and interventions

Interventions

  • Etrolizumab Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 11, 2014
Primary completion
Apr 5, 2020
Completion
Apr 5, 2020
Last update posted
Aug 18, 2021

2014 – 2020

United States locations

U.S. sites
33
U.S. states
17
U.S. cities
32
Facility City State ZIP Site status
University of California, Irvine Medical Center Orange California 92868
Clinical Applications Laboratories, Inc. San Diego California 92103
University of California at San Francisco San Francisco California 94115
Ventura Clinical Trials Ventura California 93003
Peak Gastroenterology Associates; Gastroenterology Colorado Springs Colorado 80907
Clinical Research of the Rockies Lafayette Colorado 80026
West Central Gastroenterology d/b/a Gastro Florida Clearwater Florida 33762
Regenerate Clinical Trials Miami Florida 33155
IMIC, Inc Miami Beach Florida 33140
Advanced Research Institute, Inc. Trinity Florida 34655
Shafran Gastroenterology Center Winter Park Florida 32789
Northwestern University-Feinberg School of Medicine; Division of Gastroenterology and Hepatology Chicago Illinois 60611
Southwest Gastroenterology Oak Lawn Illinois 60453
Aquiant Research New Albany Indiana 47150
Louisiana Research Center, LLC Shreveport Louisiana
Commonwealth Clinical Studies Brockton Massachusetts 02302
Henry Ford Health System Detroit Michigan 48202
Center for Digestive Health Troy Michigan 48098
University of Minnesota Minneapolis Minnesota 55455
University of Mississippi Medical Center Jackson Mississippi 39216
Ehrhardt Clinical Research, LLC Belton Missouri 64012
Manhattan Clinical Research New York New York 10016
Weill Cornell Medical College-New York Presbyterian Hospital New York New York 10021
Asheville Gastroenterology Associates, P.A. Asheville North Carolina 28801
UNC at Chapel Hill - Dpt of Family Medicine; Center for Functional GI and Motility Disorders Chapel Hill North Carolina 27599
Kinston Medical Specialists Kinston North Carolina 28501
Texas Digestive Disease Consultants - Dallas Dallas Texas 75231
Texas Digestive Disease Consultants - Southlake Southlake Texas 76092
Digestive Health Specialists of Tyler Tyler Texas 75701
Ericksen Research and Development Clinton Utah 84015
University of Utah School of Medicine Salt Lake City Utah 84132
McGuire Research Institute; Gastroenterology Richmond Virginia 23249
Northwest Gastroenterology Associates Bellevue Washington 98004

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 71 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02165215, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 18, 2021 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02165215 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →